Up next

Autoplay

Exploring the Impact of Anti-PD-1 and Anti-PD-L1 Agents in Merkel Cell Carcinoma

3 Views • 07/17/23
Share
Embed
administrator
administrator
Subscribers
0

Suzanne L. Topalian, MD, director, Melanoma Program, professor of Surgery, Johns Hopkins Medicine, discusses the impact of anti-PD-1 and anti-PD-L1 agents in the treatment of merkel cell carcinoma.

Show more
0 Comments sort Sort By
Facebook Comments

Up next

Autoplay